hopf anemia09
DESCRIPTION
CA-3 lecture on Anemia and TransfusionTRANSCRIPT
![Page 1: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/1.jpg)
The Transfusion Trigger: When Should You Give Red Cells?
Harriet W. Hopf, MDProfessor of Anesthesiology
University of Utah
![Page 2: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/2.jpg)
Goals To understand
the effect of anemia on oxygen transport mechanisms that compensate for anemia the risks of transfusion the concept of a transfusion trigger
![Page 3: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/3.jpg)
Objective Participants will be able persuasively to
defend their decision to transfuse / not to transfuse red cells
![Page 4: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/4.jpg)
Why Transfuse Red Cells?
![Page 5: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/5.jpg)
Why Transfuse Red Cells? To maintain O2 delivery to organs To prevent inadequate O2 consumption
![Page 6: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/6.jpg)
How Do We Measure Need? Ideal
Tissue oxygen Good-- but not practical
O2ER (VO2/DO2) Madjdpour and Spahn. BJA 2005; 95:33-42
Real Hemoglobin Hemodynamics
![Page 7: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/7.jpg)
Physiologic Effects of Anemia
Why is there a wide range of “normal” and “acceptable” hemoglobin?
![Page 8: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/8.jpg)
Physiologic Effects of Anemia Compensate by increased cardiac output
CO = HR X SV HR increases 4 bpm / g Hb SV increases as well
Increased contractility (active) Decreased SVR (passive) Increased venous return (passive)
Weiskopf et al. Transfusion 2003; 43: 235-40
![Page 9: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/9.jpg)
Physiologic Effects of Anemia Under anesthesia, no HR increase Increased CO is from increased SV
Majdpour and Spahn. BJA 2005; 95:33-42.
![Page 10: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/10.jpg)
Fick’s Principle
![Page 11: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/11.jpg)
Fick’s Principle
CO = VO2 / AVDO2
AVDO2 = CaO2-CvO2
CO2 = SO2(HbX1.34) + PO2(0.003) mL O2 / dL blood
![Page 12: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/12.jpg)
Does Dissolved Oxygen Matter?
![Page 13: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/13.jpg)
Hemoglobin bound oxygen
Hb (g/dL)
PaO2 (mmHg)14 10 7 3
CaO2
100
18.76 13.40 9.38 4.02
50018.76 13.40 9.38 4.02
200018.76 13.40 9.38 4.02
![Page 14: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/14.jpg)
Dissolved Oxygen
Hb (g/dL)
PaO2 (mmHg)14 10 7 3
CaO2
100
0.30 0.30 0.30 0.30
5001.50 1.50 1.50 1.50
20006.00 6.00 6.00 6.00
![Page 15: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/15.jpg)
Putting it all together
Hb (g/dL)
PaO2 (mmHg)14 10 7 3
CaO2
100
18.76
0.30
19.06
13.40
0.30
13.70
9.38
0.30
9.68
4.02
0.30
4.32
500
18.76
1.50
20.26
13.40
1.50
14.90
9.38
1.50
10.88
4.02
1.50
5.52
2000
18.76
6.00
24.76
13.40
6.00
19.40
9.38
6.00
15.38
4.02
6.00
10.02
![Page 16: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/16.jpg)
Does Dissolved Oxygen Matter?
![Page 17: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/17.jpg)
What if you can’t transfuse?
![Page 18: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/18.jpg)
What if you can’t transfuse? Administer 100% oxygen
Equivalent to 1-1.5 g/dL Hb 1 g Hb fully saturated = 1.34 mL O2
PaO2 500 mm Hg = 1.5 mL O2
PaO2 300 mm Hg = 0.9 mL O2
Weiskopf et al. Anesthesiology, 96(4), 871-7, 2002.
![Page 19: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/19.jpg)
Dissolved Oxygen Matters!!!
Hb (g/dL)
PaO2 (mmHg)14 10 7 3
CaO2
100
18.76
0.30
19.06
13.40
0.30
13.70
9.38
0.30
9.68
4.02
0.30
4.32
500
18.76
1.50
20.26
13.40
1.50
14.90
9.38
1.50
10.88
4.02
1.50
5.52
2000
18.76
6.00
24.76
13.40
6.00
19.40
9.38
6.00
15.38
4.02
6.00
10.02
![Page 20: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/20.jpg)
What Happens to AVDO2?
Normal AVDO2 using Fick’s Equation Hb 14 g/dL
CO 50 dL / min (5 Lpm) VO2 250 mL O2 / min
AVDO2 = 250/50 = 5 CaO2 19 mL O2/dL blood CvO2 14 mL O2/dL blood p50 CvO2 = 7
![Page 21: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/21.jpg)
What if AVDO2 Doesn’t Change?
Hb (g/dL)
PaO2 (mmHg)14 10
CaO2
100
18.76
0.30
19.06
13.40
0.30
13.70
13.7 - 5 = 8.7
Close enough to 7!!!
![Page 22: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/22.jpg)
What Happens to AVDO2? Assume CO can increase
Hb 7 g/dL CO 100 dL / min (10 Lpm) VO2 250 mL O2 / min
AVDO2 = 250/100 = 2.5
![Page 23: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/23.jpg)
What if AVDO2 Does Change?
Hb (g/dL)
PaO2 (mmHg)14 10 7
CaO2
100
18.76
0.30
19.06
13.40
0.30
13.70
9.38
0.30
9.68
CvO2
AVDO2 = 514.06 8.70 4.68
CvO2
AVDO2 = 2.516.56 11.20 7.18
![Page 24: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/24.jpg)
What if you can’t transfuse?
Maximize CaO2
FiO2 1.0 Hyperbaric oxygen (intermittent)
Minimize VO2
Intubate Paralyze Sedate Cool (?) to 35.5C
![Page 25: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/25.jpg)
What if you can’t transfuse? Maximize CO
Volume Goal is isovolemia Consider TEE guidance Don’t measure Hb!
Don’t use dopamine Increased VO2 mostly cardiac
![Page 26: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/26.jpg)
Dissolved Oxygen Matters!!!
Hb (g/dL)
PaO2 (mmHg)14 10 7 3
CaO2
100
18.76
0.30
19.06
13.40
0.30
13.70
9.38
0.30
9.68
4.02
0.30
4.32
500
18.76
1.50
20.26
13.40
1.50
14.90
9.38
1.50
10.88
4.02
1.50
5.52
2000
18.76
6.00
24.76
13.40
6.00
19.40
9.38
6.00
15.38
4.02
6.00
10.02
![Page 27: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/27.jpg)
Risks of Transfusion Infection
HIV 1: 500K-1500K HBV 1:30K-200K HCV 1: 2000K-3000K Bacterial 1:28K-43K Malaria 1:4000K vCJD Recent reports
Majdpour and Spahn. BJA 2005; 95:33-42.
![Page 28: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/28.jpg)
Risks of Transfusion Transfusion Reaction 1:13K Mistransfusion 1:14K-18K TRALI 1:5K-529K
Expensive Limited supply
Majdpour and Spahn. BJA 2005; 95:33-42.
![Page 29: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/29.jpg)
Risks of Transfusion Cancer recurrence Surgical site infection Mortality
Role for leucoreduction? Old vs. new blood?
Koch et al, NEJM 358:1229, 2008 Weiskopf et al, Anesth. 104:911, 2006
Majdpour and Spahn. BJA 2005; 95:33-42.
![Page 30: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/30.jpg)
Transfusion Guidelines Are there guidelines?
ASA Guidelines, Anesth 105:198-208, 2006.
Are they based on data? “strongly agree” transfuse < 6 g/dL “strongly agree” don’t transfuse >10g/dL
How good are physicians at following them?
![Page 31: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/31.jpg)
Joint Commission Patient Blood Management Performance Measures Project
Transfusion Consent RBC Transfusion Indication Plasma Transfusion Indication Platelet Transfusion Indication Blood Administration Indication Preoperative Anemia Screen Preoperative Blood Type / Antibody Screen
http://www.jointcommission.org/patient_blood_management_performance_measures_project/
![Page 32: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/32.jpg)
Transfusion Trigger Really a TARGET not a TRIGGER Healthy patient
7 g / dL Cardiopulmonary disease
10 g / dL (?8-9) Prevent tachycardia
![Page 33: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/33.jpg)
What does this mean? Healthy patient, Hb 14 g/dL Assume 500 mL (1 unit) whole blood loss = 1
g/dL Hb decrease Assume volume replaced EBL >3500 mL before consider transfusion
![Page 34: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/34.jpg)
How low can you go? Unmedicated, healthy volunteers at rest
Hb 5 g / dL No VO2-DO2 dependency Fatigued Mild cognitive impairment
Slightly slower and less accurate Still in normal range Reversed by RBC transfusion at Hb 7 g/dL Reversed by 100% O2 via NRB
Weiskopf et al. Anesthesiology, 96(4), 871-7, 2002.
![Page 35: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/35.jpg)
What about surgical patients? Anemia increases 30-day mortality, CV
complications, and LOS Non-cardiac surgery
Polycythemia similar effects Wu et al. JAMA 297:2481, 2007 (98% men)
Colorectal surgery ~50% women but not analyzed separately Leichtle et al, J Am Coll Surg 212:187, 20011
Cardiac surgery Koch et al, Crit Care Med 34:1608, 2008
![Page 36: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/36.jpg)
How Should We Manage Anemia?
Is anemia a marker for disease or inherently causative?
Preoperative treatment: 2 weeks oral iron (200 mg) reduces transfusion
9.4 vs 27.4%, p<0.05 Okuyama et alSurg Today 35:36, 2005
ESA reduces transfusion, increases DVT Laupacis and Fergusson, Transfus Med 8:309, 1998
![Page 37: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/37.jpg)
How Should We Manage Anemia?
Is anemia a marker for disease or inherently causative?
Risk-adjusted, propensity-matched ≥4 U blood predicts increases:
Mortality Infection LOS
Dunne et al, J Surg Res 102:237, 2002
![Page 38: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/38.jpg)
Critical Care Transfusion RCT
838 patients, Hb <9 g/dL, within 72 h of admit Trigger <7 Target 7-9 Trigger <10 Target 10-12
Hebert et al. NEJM, 1999; 340:409-17.
![Page 39: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/39.jpg)
Critical Care Transfusion RCT
Trigger30d Mortality
<7 g / dL <10 g/dL P value
Overall 18.7 23.3 0.11
APACHE II <21
8.7 16.1 0.03
Age <55 yr 5.7 13 0.02
CV Disease 20.5 22.9 0.69
![Page 40: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/40.jpg)
Table 3. Unadjusted Rates of Outcomes and Adjusted Results of Cox Regression Predicting 30-Day Death and Death or Recurrent Myocardial Infarction Using Transfusion as a Time-Dependent
Covariate.
Rao, S. V. et al. JAMA 2004;292:1555-1562
Copyright restrictions may apply.
HCT 25% best cut-off for transfusion
![Page 41: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/41.jpg)
Individualize Transfusion target (7 vs. 10 vs. 8…) Acute vs. chronic anemia Rate of bleeding Hemodynamics
What about ADLs? Should target differ in men and women?
![Page 42: Hopf anemia09](https://reader035.vdocuments.net/reader035/viewer/2022062307/5583bbb6d8b42a410e8b4969/html5/thumbnails/42.jpg)
Summary Transfusions of RBC can be life-saving Also cause serious morbidity and mortality Individualize therapy
Underlying disease Adequacy of compensatory responses Rate of bleeding Starting point